164 related articles for article (PubMed ID: 17490876)
1. Evaluation of 4'-substituted bicyclic pyridones as non-steroidal inhibitors of steroid 5alpha-reductase.
McCarthy AR; Hartmann RW; Abell AD
Bioorg Med Chem Lett; 2007 Jul; 17(13):3603-7. PubMed ID: 17490876
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel 2-pyridone peptidomimetic falcipain 2/3 inhibitors.
Verissimo E; Berry N; Gibbons P; Cristiano ML; Rosenthal PJ; Gut J; Ward SA; O'Neill PM
Bioorg Med Chem Lett; 2008 Jul; 18(14):4210-4. PubMed ID: 18554905
[TBL] [Abstract][Full Text] [Related]
3. Phenylimidazole derivatives as new inhibitors of bacterial enoyl-ACP reductase FabK.
Kitagawa H; Ozawa T; Takahata S; Iida M
Bioorg Med Chem Lett; 2007 Sep; 17(17):4982-6. PubMed ID: 17600706
[TBL] [Abstract][Full Text] [Related]
4. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E
Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484
[TBL] [Abstract][Full Text] [Related]
5. Neighboring group participation. Part 15. Stereoselective synthesis of some steroidal tetrahydrooxazin-2-ones, as novel presumed inhibitors of human 5alpha-reductase.
Wölfling J; Hackler L; Mernyák E; Schneider G; Tóth I; Szécsi M; Julesz J; Sohár P; Csámpai A
Steroids; 2004 Jul; 69(7):451-60. PubMed ID: 15246775
[TBL] [Abstract][Full Text] [Related]
6. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
Pérez-Ornelas V; Cabeza M; Bratoeff E; Heuze I; Sánchez M; Ramírez E; Naranjo-Rodríguez E
Steroids; 2005 Mar; 70(3):217-24. PubMed ID: 15763601
[TBL] [Abstract][Full Text] [Related]
7. Selective non-steroidal inhibitors of 5 alpha-reductase type 1.
Occhiato EG; Guarna A; Danza G; Serio M
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):1-16. PubMed ID: 15026079
[TBL] [Abstract][Full Text] [Related]
8. Novel C-6 substituted and unsubstituted pregnane derivatives as 5alpha-reductase inhibitors and their effect on hamster flank organs diameter size.
Cabeza M; Zambrano A; Heuze I; Carrizales E; Palacios A; Segura T; Valencia N; Bratoeff E
Steroids; 2009 Oct; 74(10-11):793-802. PubMed ID: 19406144
[TBL] [Abstract][Full Text] [Related]
9. 3,3-diphenylpentane skeleton as a steroid skeleton substitute: novel inhibitors of human 5alpha-reductase 1.
Hosoda S; Hashimoto Y
Bioorg Med Chem Lett; 2007 Oct; 17(19):5414-8. PubMed ID: 17686629
[TBL] [Abstract][Full Text] [Related]
10. Novel 5alpha-reductase inhibitors: synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids.
Salem OI; Frotscher M; Scherer C; Neugebauer A; Biemel K; Streiber M; Maas R; Hartmann RW
J Med Chem; 2006 Jan; 49(2):748-59. PubMed ID: 16420060
[TBL] [Abstract][Full Text] [Related]
11. First synthesis of alpha-aminoalkyl-(N-substituted)thiocarbamoyl-phosphinates: inhibitors of aminopeptidase N (APN/CD13) with the new zinc-binding group.
Grzywa R; Oleksyszyn J
Bioorg Med Chem Lett; 2008 Jul; 18(13):3734-6. PubMed ID: 18524593
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5alpha-reductases 1 and 2.
Ferrali A; Menchi G; Occhiato EG; Danza G; Mancina R; Serio M; Guarna A
Bioorg Med Chem Lett; 2005 Jan; 15(1):145-8. PubMed ID: 15582428
[TBL] [Abstract][Full Text] [Related]
13. 4-(1H-indazol-5-yl)-6-phenylpyrimidin-2(1H)-one analogs as potent CDC7 inhibitors.
Shafer CM; Lindvall M; Bellamacina C; Gesner TG; Yabannavar A; Jia W; Lin S; Walter A
Bioorg Med Chem Lett; 2008 Aug; 18(16):4482-5. PubMed ID: 18672368
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a pharmacophore model for inhibitors of aldosterone synthase (CYP11B2).
Ulmschneider S; Negri M; Voets M; Hartmann RW
Bioorg Med Chem Lett; 2006 Jan; 16(1):25-30. PubMed ID: 16246562
[TBL] [Abstract][Full Text] [Related]
15. Cyclohex-1-ene carboxylic acids: synthesis and biological evaluation of novel inhibitors of human 5 alpha reductase.
Baston E; Salem OI; Hartmann RW
Arch Pharm (Weinheim); 2003 Mar; 336(1):31-8. PubMed ID: 12666251
[TBL] [Abstract][Full Text] [Related]
16. Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines.
Perry B; Alexander R; Bennett G; Buckley G; Ceska T; Crabbe T; Dale V; Gowers L; Horsley H; James L; Jenkins K; Crépy K; Kulisa C; Lightfoot H; Lock C; Mack S; Morgan T; Nicolas AL; Pitt W; Sabin V; Wright S
Bioorg Med Chem Lett; 2008 Aug; 18(16):4700-4. PubMed ID: 18644721
[TBL] [Abstract][Full Text] [Related]
17. Substituted 6-phenyl-2-naphthols. Potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1): design, synthesis, biological evaluation, and pharmacokinetics.
Marchais-Oberwinkler S; Kruchten P; Frotscher M; Ziegler E; Neugebauer A; Bhoga U; Bey E; Müller-Vieira U; Messinger J; Thole H; Hartmann RW
J Med Chem; 2008 Aug; 51(15):4685-98. PubMed ID: 18630892
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitors.
Devreux V; Wiesner J; Jomaa H; Van der Eycken J; Van Calenbergh S
Bioorg Med Chem Lett; 2007 Sep; 17(17):4920-3. PubMed ID: 17583502
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studies.
Lin X; Murray JM; Rico AC; Wang MX; Chu DT; Zhou Y; Del Rosario M; Kaufman S; Ma S; Fang E; Crawford K; Jefferson AB
Bioorg Med Chem Lett; 2006 Aug; 16(16):4163-8. PubMed ID: 16765046
[TBL] [Abstract][Full Text] [Related]
20. 5α-reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives.
Al-Mohizea AM; Al-Omar MA; Abdalla MM; Amr AG
Int J Biol Macromol; 2012 Jan; 50(1):171-9. PubMed ID: 22057085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
